STEMBIOSYS INC.

Profile

Company Names

STEMBIOSYS INC.

Addresses

3463 MAGIC DRIVE, SUITE 110, SAN ANTONIO, TX 78229

12500 NETWORK BOULEVARD, SUITE 105, SAN ANTONIO, TX 78249

Phone Numbers

(210) 877-9323
(210)614-3355

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$7,835,367.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-05-03 
$1,397,565.00 
$3,000,000.00 
$1,602,435.00 
Equity 
2
2016-04-14 
$4,060,000.00 
$4,262,000.00 
$202,000.00 
Equity, Debt 
1
2013-01-31 
$2,377,802.00 
$8,000,000.00 
$5,622,198.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CATHERINE 
 
BURZIK 
DIRECTOR
STEMBIOSYS INC.
PAUL 
 
CASTELLA 
DIRECTOR
BIO2 MEDICAL INC   |  VIROXIS CORP   |  BI02 MEDICAL, INC.   |  CYTOCENTRICS, INC.   |  STEMBIOSYS INC.   |  CYTBIOSCIENCE, INC.   |  CYTOBIOSCIENCE, INC.   |  HERA BIOTECH, INC.   |  INNOVATIVE TRAUMA CARE INC.   |  TROPOFLEX INC.   |  TROPOGENIX, INC.
JEAN 
 
CHEEVER 
DIRECTOR
TOXIE BROADWAY LTD LIABILITY CO   |  STEMBIOSYS INC.
XIAO-DONG 
 
CHEN 
DIRECTOR
STEMBIOSYS INC.
XIAO-DONG 
 
CHEN, M.D. 
EXECUTIVE OFFICER, DIRECTOR
STEMBIOSYS INC.
IAN 
 
CLEMENTS 
DIRECTOR
TARGETED TECHNOLOGY FUND II, LP   |  CYTOCENTRICS, INC.   |  STEMBIOSYS INC.   |  CYTBIOSCIENCE, INC.   |  CYTOBIOSCIENCE, INC.   |  MIRUM PHARMACEUTICALS, INC.
STEVEN 
 
DAVIS 
DIRECTOR
RUELALA, INC.   |  THERAGENE PHARMACEUTICALS, INC.   |  5 ARCH INCOME FUND 1, LLC   |  STEMBIOSYS INC.   |  LATTITUDE INTERNATIONAL, INC.   |  PHILTER LABS INC   |  IMX, LLC   |  FABRI INC.
STEVEN 
 
DAVIS, M.D. 
EXECUTIVE OFFICER, DIRECTOR
STEMBIOSYS INC.
JOHN 
W 
FEIK 
DIRECTOR
STEMBIOSYS INC.
EDWARD 
 
GRIFFEY 
EXECUTIVE OFFICER
STEMBIOSYS INC.
MARK 
 
HORSEY 
EXECUTIVE OFFICER
RAPAMYCIN HOLDINGS, INC.   |  STEMBIOSYS INC.
MARK 
D 
HORSEY 
EXECUTIVE OFFICER, DIRECTOR
STEMBIOSYS INC.
ROBERT 
 
HUTCHENS 
EXECUTIVE OFFICER, DIRECTOR
STEMBIOSYS INC.
ROBERT 
S 
LANGER 
DIRECTOR
PERVASIS THERAPEUTICS INC   |  SOFT TISSUE REGENERATION, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  BIND BIOSCIENCES INC   |  EGEN, INC.   |  STEMBIOSYS INC.
PETER 
 
SAVAS 
EXECUTIVE OFFICER, DIRECTOR
STEMBIOSYS INC.   |  TARGETED TECHNOLOGY FUND II, LP   |  AERIN MEDICAL, INC.
CHEN 
 
XIAO-DONG 
DIRECTOR
STEMBIOSYS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-06-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-03 
2018-05-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-04-14 
2016-12-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-04-14 
2013-07-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-31 
2013-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#